These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 15919476

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Single-shot antithymocyte globulin (ATG) induction for pancreas/kidney transplantation: ATG-Fresenius versus Thymoglobulin.
    Schulz T, Papapostolou G, Schenker P, Kapischke M.
    Transplant Proc; 2005 Mar; 37(2):1301-4. PubMed ID: 15848703
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rejection after simultaneous pancreas-kidney transplantation.
    Arbogast H, Malaise J, Illner WD, Tarabichi A, Dieterle C, Landgraf R, Land W, Euro-SPK Study Group.
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.
    Sundberg AK, Rohr MS, Hartmann EL, Adams PL, Stratta RJ.
    Clin Transplant; 2004 May; 18 Suppl 12():61-6. PubMed ID: 15217410
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Induction therapy in lung transplantation: initial single-center experience comparing daclizumab and antithymocyte globulin.
    Lischke R, Simonek J, Davidová R, Schützner J, Stolz AJ, Vojácek J, Burkert J, Pafko P.
    Transplant Proc; 2007 May; 39(1):205-12. PubMed ID: 17275507
    [Abstract] [Full Text] [Related]

  • 14. One-year outcomes in simultaneous kidney-pancreas transplant recipients receiving an alternative dosing regimen of daclizumab.
    Stratta RJ, Alloway RR, Lo A, Hodge EE, PIVOT Study Group.
    Transplant Proc; 2004 May; 36(4):1080-1. PubMed ID: 15194375
    [Abstract] [Full Text] [Related]

  • 15. A prospective, randomized, multicenter study evaluating the safety and efficacy of two dosing regimens of daclizumab compared to no antibody induction in simultaneous kidney-pancreas transplantation: results at 3 years.
    Stratta RJ, Alloway RR, Lo A, Hodge EE.
    Transplant Proc; 2005 Oct; 37(8):3531-4. PubMed ID: 16298651
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Combined pancreas kidney transplantation after isolated kidney transplantation].
    Schulz T, Schenker P, Flecken M, Schäffer M, Viebahn R, Kapischke M.
    Zentralbl Chir; 2005 Apr; 130(2):132-6. PubMed ID: 15849657
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
    Lü TM, Yang SL, Wu WZ, Tan JM.
    Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.